Variables | Median(range)/number(ratio) |
---|---|
Female | 80/ (64.5%) |
Age at reoperation | 42 (13–73) |
Time span between initial surgery and reoperation (months) | 16 (5–38) |
Pre-reop unstim-Tg (ng/mL)a | 11.12 (0.1–1000) |
Post-reop unstim-Tg (ng/mL)b | 2.04 (0.1–600) |
Tg different between pre-/post-reoperation (ng/mL)c | 5.03 (− 499.82–999.61) |
Frequency of pre-reop RAI therapy | 2 (1–8) |
Dose of pre-reop RAI therapy (mCi) | 250 (50–750) |
RAI-avidity character | |
 Avid | 60 (48.4%) |
 Refractory | 55 (44.4%) |
 Unknown | 9 (7.2%) |
Number of pathologically proven metastatic lymph node at reoperation | 4 (1–19) |
Largest dimision of positive lymph node (cm) | 1.9 (0.4–5) |
Metastatic lymph node with extranodal extension | 39 (31.4%) |
Metastatic lymph node with squamous dedifferentiation | 6 (4.8%) |